| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5906221 | Gene | 2013 | 6 Pages |
Abstract
Our findings confirm that the GNPTAB gene presents broad allelic heterogeneity and suggests that, in Brazilian ML II and III patients, screening for mutations should begin at exon 19 of the GNPTAB gene. Further analyses will be conducted on patients in whom both pathogenic mutations have not been found in this study.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
G.K. Cury, U. Matte, O. Artigalás, T. Alegra, R.V. Velho, F. Sperb, M.G. Burin, E.M. Ribeiro, C.M. Lourenço, C.A. Kim, E.R. Valadares, M.F. Galera, A.X. Acosta, I.V.D. Schwartz,